Hydration status in patients hospitalized with acute decompensated heart failure depending on the severity of glucose metabolism disorder

被引:1
作者
Tolkacheva, V. V. [1 ]
Diane, M. L. [1 ]
Khutsishvili, N., I [1 ]
Montoya, Cabello F. E. [1 ]
Nazarov, I. S. [1 ]
Smirnov, I. P. [1 ]
Galochkin, S. A. [1 ]
Kobalava, Zh D. [1 ]
机构
[1] Peoples Friendship Univ Russia RUDN Univ, 8 Mikluho Maklaya Str, Moscow 117198, Russia
来源
BYULLETEN SIBIRSKOY MEDITSINY | 2023年 / 22卷 / 04期
关键词
heart failure; congestion assessment; NT-proBNP; lung ultrasound; liver Fibroscan testing; glucose metabolism disorder; DIABETES-MELLITUS; OUTCOMES; ASSOCIATION; MORTALITY; DISEASE; RISK;
D O I
10.20538/1682-0363-2023-4-114-121
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To study the hydration status according to clinical parameters and laboratory and instrumental research findings at admission and discharge in patients hospitalized with acute decompensated heart failure (ADHF), depending on the severity of glucose metabolism disorder. Materials and methods. The study included 280 patients (53% men, average age 70.1 +/- 10.8 years) with ADHF. 72.5% of patients had arterial hypertension in the medical history, 60% of patients had coronary artery disease. In all patients, the level of glycated hemoglobin (HbA1c) was determined to assess the glucose metabolism status. The patients were divided into groups depending on the results obtained: at HbA1c values < 5.7%, patients were included in the group without glucose metabolism disorders, at HbA1c of 5.7-6.4% - in the prediabetes group, at HbA1c = 6.5% - in the type 2 diabetes group. The patients underwent a standard physical examination at admission and at discharge, as well as a clinical and comprehensive assessment of congestion (determination of N-terminal pro B-type natriuretic peptide (NT-proBNP), lung ultrasound, liver Fibroscan testing, including calculation of a controlled attenuation parameter, bioimpedance analysis of the body). Results. The frequency of glucose metabolism disorders in patients hospitalized with ADHF was 57.5% (n = 161), while prediabetes was detected in 17.1% of patients (n = 48) and type 2 diabetes - in 40.4% (n = 113) of cases. Congestion at admission was detected in all patients. A significantly higher frequency of residual (61%) and a lower frequency of subclinical congestion (10%) were revealed in patients with ADHF and type 2 diabetes, compared to patients without glucose metabolism disorders (39% for residual congestion, 27% for subclinical congestion) and prediabetes (40% for residual congestion, 25% for subclinical congestion), respectively. There were no significant differences in the frequency of euvolemia at discharge, depending on the glucose metabolism disorder. Conclusion..o assess congestion phenomena at discharge, it is necessary to use clinical, laboratory, and instrumental assessments for patients with ADHF and glucose metabolism disorders. However, in patients with ADHF and prediabetes, it is preferable to focus on the laboratory and instrumental assessment of congestion, while in patients with ADHF and type 2 diabetes, both clinical and laboratory and instrumental assessment of congestion should be performed.
引用
收藏
页码:114 / 121
页数:8
相关论文
共 19 条
[1]   Effects of digoxin on morbidity and mortality in diastolic heart failure: The ancillary Digitalis Investigation Group trial [J].
Ahmed, Ali ;
Rich, Michael W. ;
Fleg, Jerome L. ;
Zile, Michael R. ;
Young, James B. ;
Kitzman, Dalane W. ;
Love, Thomas E. ;
Aronow, Wilbert S. ;
Adams, Kirkwood F., Jr. ;
Gheorghiade, Mihai .
CIRCULATION, 2006, 114 (05) :397-403
[2]   Management of patients with diabetes and heart failure with reduced ejection fraction: An international comparison [J].
Arnold, Suzanne V. ;
Yap, Jonathan ;
Lam, Carolyn S. P. ;
Tang, Fengming ;
Tay, Wan T. ;
Teng, Tiew H. K. ;
McGuire, Darren K. ;
Januzzi, James L. ;
Fonarow, Gregg C. ;
Masoudi, Frederick A. ;
Kosiborod, Mikhail .
DIABETES OBESITY & METABOLISM, 2019, 21 (02) :261-266
[3]   Response to Exercise Training and Outcomes in Patients With Heart Failure and Diabetes Mellitus: Insights From the HF-ACTION Trial [J].
Banks, Adam Z. ;
Mentz, Robert J. ;
Stebbins, Amanda ;
Mikus, Catherine R. ;
Schulte, Phillip J. ;
Fleg, Jerome L. ;
Cooper, Lawton S. ;
Leifer, Eric S. ;
Badenhop, Dalynn T. ;
Keteyjan, Steven J. ;
Pina, Ileana L. ;
Kitzman, Dalane W. ;
Fiuzat, Mona ;
Whellan, David J. ;
Kraus, William E. ;
O'Connor, Christopher M. .
JOURNAL OF CARDIAC FAILURE, 2016, 22 (07) :485-491
[4]   Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: A retrospective analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Prevention Trial [J].
Das, SR ;
Drazner, MH ;
Yancy, CW ;
Stevenson, LW ;
Gersh, BJ ;
Dries, DL .
AMERICAN HEART JOURNAL, 2004, 148 (05) :883-888
[5]   Association Between Diabetes and 1-Year Adverse Clinical Outcomes in a Multinational Cohort of Ambulatory Patients With Chronic Heart Failure: Results From the ESC-HFA Heart Failure Long-Term Registry [J].
Dauriz, Marco ;
Targher, Giovanni ;
Laroche, Cecile ;
Temporelli, Pier Luigi ;
Ferrari, Roberto ;
Anker, Stephan ;
Coats, Andrew ;
Filippatos, Gerasimos ;
Crespo-Leiro, Maria ;
Mebazaa, Alexandre ;
Piepoli, Massimo F. ;
Maggioni, Aldo P. ;
Tavazzi, Luigi .
DIABETES CARE, 2017, 40 (05) :671-678
[6]   Association of heart failure severity with risk of diabetes: a Danish nationwide cohort study [J].
Demant, Malene N. ;
Gislason, Gunnar H. ;
Kober, Lars ;
Vaag, Allan ;
Torp-Pedersen, Christian ;
Andersson, Charlotte .
DIABETOLOGIA, 2014, 57 (08) :1595-1600
[7]   Integrative Assessment of Congestion in Heart Failure Throughout the Patient Journey [J].
Girerd, Nicolas ;
Seronde, Marie-France ;
Coiro, Stefano ;
Chouihed, Tahar ;
Bilbault, Pascal ;
Braun, Francois ;
Kenizou, David ;
Maillier, Bruno ;
Nazeyrollas, Pierre ;
Roul, Gerard ;
Fillieux, Ludivine ;
Abraham, William T. ;
Januzzi, James, Jr. ;
Sebbag, Laurent ;
Zannad, Faiez ;
Mebazaa, Alexandre ;
Rossignol, Patrick .
JACC-HEART FAILURE, 2018, 6 (04) :273-285
[8]   Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications [J].
Heerspink, Hiddo J. L. ;
Perkins, Bruce A. ;
Fitchett, David H. ;
Husain, Mansoor ;
Cherney, David Z. I. .
CIRCULATION, 2016, 134 (10) :752-772
[9]   Diabetes lowers six-minute walk test performance in heart failure [J].
Ingle, L ;
Reddy, P ;
Clark, AL ;
Cleland, JGF .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (09) :1909-1910
[10]   Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes [J].
Kristensen, Soren L. ;
Jhund, Pardeep S. ;
Lee, Matthew M. Y. ;
Kober, Lars ;
Solomon, Scott D. ;
Granger, Christopher B. ;
Yusuf, Salim ;
Pfeffer, Marc A. ;
Swedberg, Karl ;
McMurray, John J. V. .
CARDIOVASCULAR DRUGS AND THERAPY, 2017, 31 (5-6) :545-549